Schroeder v. Hutchinson Regional Medical Center

District Court, D. Kansas·Decided October 5, 2023·No. 2:17-cv-02060·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF KANSAS

UNITED STATES OF AMERICA ) ex rel. THOMAS SCHROEDER, ) ) Relator, ) ) vs. ) Case No. 17-2060-DDC-BGS ) MEDTRONIC, INC., et al., ) ) Defendants. ) )

MEMORANDUM & ORDER DENYING MOTION TO AMEND SCHEDULING ORDER

Now before the Court is Relator’s “Motion to Amend Scheduling Order to Reopen Fact Discovery for Limited Purposes.” (Doc. 390.) Having reviewed the submissions of the parties, Relator’s motion is DENIED for the reasons set forth herein. BACKGROUND Relator Thomas Schroeder (“Relator”) brings this action against Defendants Medtronic, Inc. (“Medtronic”), Covidien L.P. (“Covidien”), Hutchison Regional Medical Center (“HRMC”) and Wichita Radiological Group, P.A. (“WRG”) under the False Claims Act, 31 U.S.C. § 3729, alleging Defendants Medtronic and Covidien paid illegal remuneration to induce purchase of medical devices in an effort to recover monies for the Veterans Administration. Relator further alleges that Medtronic employees were rewarded for marketing or encouraging the “overuse” and “off label” use of Peripheral Disease devices. (Id.) Relator’s Fifth Amended Complaint (“operative Complaint” or “the Complaint”) was filed on October 24, 2022. (Doc. 233.) Therein, Relator alleges that HRMC and Medtronic violated the Federal anti-kickback statute, 42 U.S.C § 1320a-7b(b) (“AKS”), “by exchanging medical devices free of charge as part of larger bulk purchases of other devices.” (Doc. 390, at 2.) According to Relator, these devices were “illegal remuneration provided to induce these sales.” (Id.) HRMC and Medtronic filed their Answers to the operative Complaint on August 24, 2023, and August 31, 2023 (Docs. 379, 384), several months after the close of fact discovery on April 30, 2023.1 (Doc. 301, text Order.) The case progressed this way because HRMC and Medtronic filed Motions to Dismiss in response to the operative Complaint (Docs. 243, 244) on November 21,

2022. The District Court, however, permitted discovery to proceed while these dispositive motions were pending. The motions were ruled upon by the District Court on August 10, 2023. (Doc. 368.) Thereafter, HRMC and Medtronic filed the above-referenced Answers to the operative Complaint, which contain the “safe harbor” affirmative defense to liability under the AKS. (Doc. 379, at 25; Doc. 384, at 24.) The defense relates to certain exceptions – or “safe harbors” – to sales between device manufacturers and buyers. This affirmative defense had also been included in HRMC’s Answer to Relator’s Third Amended Complaint, which was filed on November 23, 2021.2 (Doc. 77, at 23.) Relator brings the present motion, arguing that because discovery closed before Defendants pled the safe harbor affirmative defense, he should be allowed “very brief and limited discovery” into the basis for this affirmative defense. (Doc. 390, at 2.) Defendants generally argue that Relator’s motion should fail because he has failed to establish the requisite good cause to amend the

1 The case remains in the expert discovery phase until April 12, 2024. (Doc. 361, at 2.) The Pretrial Conference is set for May 8, 2024, with dispositive motions due June 7, 2024. (Id.) 2 Medtronic did not answer the Third Amended Complaint, but instead filed a Partial Motion to Dismiss. (Doc. 75.) The Fourth Amended Complaint was filed on May 25, 2022. (Doc. 127.) All Defendants filed partial or full motions to dismiss the Fourth Amended Complaint. Therefore, Defendants did not answer (and plead affirmative defenses to) the Fourth Amended Complaint. Before the dispositive motions relating to the Fourth Amended Complaint were ruled upon, Relator was granted leave (Doc. 232) to file the Fifth Amended Complaint, which was entered on October 24, 2022 (Doc. 233). Thus, prior to answering the Fifth Amended Complaint, the last operative Answer by HRMC was the Answer to the Third Amended Complaint – which included the safe harbor affirmative defense. Scheduling Order because he was aware of the affirmative defense long before the close of fact discovery. The Court notes that Magistrate Gale’s Memorandum & Order granting Relator’s previous Motion to Amend Revised Scheduling Order for Extension of Expert Deadlines emphatically stated that “fact discovery has ended. No party may issue additional fact discovery without leave of court.” (Doc. 353, at 11 (emphasis in original).) ANALYSIS

I. Standards for Amending Scheduling Order. Rule 16(b)(4) provides that “[a] schedule may be modified only for good cause and with the judge's consent.” “In practice, this standard requires the movant to show the ‘scheduling deadlines cannot be met despite [the movant’s] diligent efforts.’” Gorsuch, Ltd., B.C. v. Wells Fargo Nat’l Bank Ass’n, 771 F.3d 1230, 1240 (10th Cir. 2014) (citing Pumpco, Inc. v. Schenker Intern., Inc., 204 F.R.D. 667, 668 (D. Colo. 2001) (quotations omitted)). See also Pfeiffer v. Eagle Mfg. Co., 137 F.R.D. 352, 355 (D. Kan. 1991); Fed.R.Civ.P. 16 advisory committee note to 1983 Amendment. The Court is “afforded broad discretion in managing the pretrial schedule.” Rimbert v. Eli Lilly & Co., 647 F.3d 1247, 1254 (10th Cir. 2011); see also Smith v. US, 834 F.2d 166, 169 (10th Cir. 1987). In determining whether to reopen discovery, the Court’s analysis is guided by the following six factors: 1) whether trial is imminent, 2) whether the request is opposed, 3) whether the non-moving party would be prejudiced, 4) whether the moving party was diligent in obtaining discovery within the guidelines established by the court, 5) the foreseeability of the need for additional discovery in light of the time allowed for discovery by the district court, and 6) the likelihood that the discovery will lead to relevant evidence.

Smith, 834 F.2d at 169; see also Rutledge v. Bd. of Cnty. Commissioners of Johnson Cnty., No. 20-2012-DDC- GEB, 2021 WL 274514, *3 (D. Kan. Jan. 27, 2021) (citation omitted) and Benjamin v. Bd. of Trustees of Barton Cnty. Cmty. Coll., No. 17-2557-JAR, 2020 WL 4785107, *2 (D. Kan. Aug. 18, 2020) (citation omitted). That stated, the lack of prejudice to the nonmovant does not, in itself, establish “good cause.” Deghand v. Wal-Mart Stores, Inc., 904 F.Supp. 1218, 1221 (D. Kan. 1995) (citations omitted). II. Application of Legal Standard to Facts of Case. In seeking to amend the Scheduling Order to reopen discovery, Relator specifically seeks permission to take one Rule 30(b)(6) deposition from Medtronic regarding where the ‘no charge’ devices given by Medtronic to HRMC would have physically come from. These no charge devices impacted the sale price of other devices, and therefore, play an essential role in any alleged ‘safe harbor’ defense under the AKS. Assuming Medtronic’s designated corporate representative has been prepared as required by Rule 30(b)(6). Relator anticipates the deposition should take no more than a few hours to complete. That is the extent of the requested discovery.

(Doc. 390, at 2-3 (footnote omitted).) Relator concedes that “some discovery” regarding the safe harbor affirmative defense occurred prior to the fact discovery deadline.

Free access — add to your briefcase to read the full text and ask questions with AI

Schroeder v. Hutchinson Regional Medical Center, (D. Kan. 2023).

Schroeder v. Hutchinson Regional Medical Center (Schroeder v. Hutchinson Regional Medical Center) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Rimbert v. Eli Lilly and Co.
647 F.3d 1247 (Tenth Circuit, 2011)
Deghand v. Wal-Mart Stores, Inc.
904 F. Supp. 1218 (D. Kansas, 1995)
Pumpco, Inc. v. Schenker International, Inc.
204 F.R.D. 667 (D. Colorado, 2001)
Pfeiffer v. Eagle Manufacturing Co.
137 F.R.D. 352 (D. Kansas, 1991)